Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Noninvasive characterization of pancreatic tumor mouse models using magnetic resonance imaging.

Farr N, Wang YN, D'Andrea S, Gravelle KM, Hwang JH, Lee D.

Cancer Med. 2017 May;6(5):1082-1090. doi: 10.1002/cam4.1062. Epub 2017 Apr 7.

2.

Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer.

Fan W, Shi W, Zhang W, Jia Y, Zhou Z, Brusnahan SK, Garrison JC.

Biomaterials. 2016 Oct;103:101-115. doi: 10.1016/j.biomaterials.2016.05.036. Epub 2016 Jun 8.

3.

Gd(III)-Dithiolane Gold Nanoparticles for T1-Weighted Magnetic Resonance Imaging of the Pancreas.

Holbrook RJ, Rammohan N, Rotz MW, MacRenaris KW, Preslar AT, Meade TJ.

Nano Lett. 2016 May 11;16(5):3202-9. doi: 10.1021/acs.nanolett.6b00599. Epub 2016 Apr 20.

4.

Molecular Imaging of Pancreatic Cancer with Antibodies.

England CG, Hernandez R, Eddine SB, Cai W.

Mol Pharm. 2016 Jan 4;13(1):8-24. doi: 10.1021/acs.molpharmaceut.5b00626. Epub 2015 Dec 10. Review.

5.

In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model.

Cui MH, Branch CA, Cahill SM, Quinn TJ, Adem A, Libutti SK, Yuan Z.

Magn Reson Med. 2015 Nov;74(5):1221-6. doi: 10.1002/mrm.25529. Epub 2014 Nov 13.

6.

A non-invasive method of quantifying pancreatic volume in mice using micro-MRI.

Paredes JL, Orabi AI, Ahmad T, Benbourenane I, Tobita K, Tadros S, Bae KT, Husain SZ.

PLoS One. 2014 Mar 18;9(3):e92263. doi: 10.1371/journal.pone.0092263. eCollection 2014.

7.

Metastatic pancreatic cancer is dependent on oncogenic Kras in mice.

Collins MA, Brisset JC, Zhang Y, Bednar F, Pierre J, Heist KA, Galbán CJ, Galbán S, di Magliano MP.

PLoS One. 2012;7(12):e49707. doi: 10.1371/journal.pone.0049707. Epub 2012 Dec 3.

8.

Empirical mathematical model for dynamic manganese-enhanced MRI of the murine pancreas for assessment of β-cell function.

Dhyani AH, Fan X, Leoni L, Haque M, Roman BB.

Magn Reson Imaging. 2013 May;31(4):508-14. doi: 10.1016/j.mri.2012.09.003. Epub 2012 Oct 25.

9.

Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model.

Ghosh SK, Uchida M, Yoo B, Ross AW, Gendler SJ, Gong J, Moore A, Medarova Z.

Int J Cancer. 2013 Apr 15;132(8):1860-7. doi: 10.1002/ijc.27872. Epub 2012 Oct 25.

10.

Tumour size measurement in a mouse model using high resolution MRI.

Montelius M, Ljungberg M, Horn M, Forssell-Aronsson E.

BMC Med Imaging. 2012 May 30;12:12. doi: 10.1186/1471-2342-12-12.

11.

Visualization of mouse pancreas architecture using MR microscopy.

Grippo PJ, Venkatasubramanian PN, Knop RH, Heiferman DM, Iordanescu G, Melstrom LG, Adrian K, Barron MR, Bentrem DJ, Wyrwicz AM.

Am J Pathol. 2011 Aug;179(2):610-8. doi: 10.1016/j.ajpath.2011.04.007. Epub 2011 May 31.

12.

Targeted nanogels: a versatile platform for drug delivery to tumors.

Murphy EA, Majeti BK, Mukthavaram R, Acevedo LM, Barnes LA, Cheresh DA.

Mol Cancer Ther. 2011 Jun;10(6):972-82. doi: 10.1158/1535-7163.MCT-10-0729. Epub 2011 Apr 25.

13.

In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model.

Partecke IL, Kaeding A, Sendler M, Albers N, Kühn JP, Speerforck S, Roese S, Seubert F, Diedrich S, Kuehn S, Weiss UF, Mayerle J, Lerch MM, Hadlich S, Hosten N, Heidecke CD, Puls R, von Bernstorff W.

BMC Cancer. 2011 Jan 28;11:40. doi: 10.1186/1471-2407-11-40.

14.

Oncogenic Ras/Src cooperativity in pancreatic neoplasia.

Shields DJ, Murphy EA, Desgrosellier JS, Mielgo A, Lau SK, Barnes LA, Lesperance J, Huang M, Schmedt C, Tarin D, Lowy AM, Cheresh DA.

Oncogene. 2011 May 5;30(18):2123-34. doi: 10.1038/onc.2010.589. Epub 2011 Jan 17.

15.

RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia.

Shields DJ, Niessen S, Murphy EA, Mielgo A, Desgrosellier JS, Lau SK, Barnes LA, Lesperance J, Bouvet M, Tarin D, Cravatt BF, Cheresh DA.

Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2189-94. doi: 10.1073/pnas.0911646107. Epub 2009 Dec 28.

16.

Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models.

Samkoe KS, Chen A, Rizvi I, O'Hara JA, Hoopes PJ, Pereira SP, Hasan T, Pogue BW.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):251-9. doi: 10.1016/j.ijrobp.2009.08.041.

17.

Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging.

Antkowiak PF, Tersey SA, Carter JD, Vandsburger MH, Nadler JL, Epstein FH, Mirmira RG.

Am J Physiol Endocrinol Metab. 2009 Mar;296(3):E573-8. doi: 10.1152/ajpendo.90336.2008. Epub 2008 Dec 30.

18.

Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis.

Murphy EA, Majeti BK, Barnes LA, Makale M, Weis SM, Lutu-Fuga K, Wrasidlo W, Cheresh DA.

Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9343-8. doi: 10.1073/pnas.0803728105. Epub 2008 Jul 7.

Supplemental Content

Support Center